Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 52

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 52
---
 is a party in which in excess of 50% of our voting power is transferred; provided that the foregoing shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by us or our indebtedness is cancelled or converted or a combination thereof; or (c) a sale, lease, exclusive license or other disposition of all or substantially all of our assets. |

| • | “good reason” means any of the following actions, if taken by us without the officer’s prior written consent: (a) a material reduction in the officer’s base salary, which we and the officer agree is a reduction of at least 10% of the officer’s base salary (unless pursuant to a salary reduction program applicable generally to our similarly situated employees); (b) a material reduction in the officer’s duties (including responsibilities and/or authorities) (with respect to Dr. Fordyce, as our President and Chief Executive Officer), provided, however, that a change in job position (including a change in title) shall not be deemed a “material reduction” in and of itself unless the officer’s new duties are materially reduced from the prior duties; (c) relocation of the officer’s principal place of employment to a place that increases the officer’s one-way commute by more than 50 miles as compared to the officer’s then-current principal place of employment immediately prior to such relocation, provided that if the officer works remotely during any period in which the officer’s regular principal place of business at a company office is closed, then neither the officer’s relocation to remote work or back to the office from remote work will be considered a relocation from the officer’s principal place of employment for the purposes of this definition; or, solely with respect to Dr. Fordyce, (d) prior to a change of control, no longer being a member of our Board or reporting to our Board as Chief Executive Officer. In order to resign for good reason, the officer must provide written notice to our Board, or with respect to Mr. Carter and Dr. Brenner, our Chief Executive Officer, within 30 days after each occurrence of the event giving rise to good reason setting forth the basis for such officer’s resignation, allow us at least 30 days from receipt of such written notice to cure such event, and if such event is not reasonably cured within such period, such officer must resign from all positions the officer then holds with the company not later than 30 days after the expiration of the cure period. |

Other Compensation